Starpharma leaps 9.5% on new Delta variant claims

MELBOURNE: Shares in Starpharma this morning soared after it announced its Viraleze Nasal Spray was

To read the full story...SUBSCRIBE NOW

Existing Subscribers Login Below:

Log In